ASX:AYAHealth Care Equipment & ServicesHealth Care Technology
Artrya Ltd
$5.360
$0.150 (2.72%)
Day Range
$5.150 – $5.470
52 Week Range
$0.930 – $6.490
Volume
849.04K
Avg Volume (10D)
615.13K
Market Cap
$873.48M
Price Chart
Market Statistics
Open$5.470
Previous Close$5.510
Day High$5.470
Day Low$5.150
52 Week High$6.490
52 Week Low$0.930
Valuation
Market Cap873.48M
Shares Outstanding162.96M
Price to Book9.48
Trading Activity
Volume849.04K
Value Traded4.54M
Bid$5.250 × 10,000
Ask$5.550 × 909
Performance
1 Day-2.72%
5 Day-7.11%
13 Week30.73%
52 Week425.49%
YTD13.80%
Technical Indicators
RSI (14)47.88
50-Day SMA$5.103
200-Day SMA$3.958
Latest News
Biotechnology
Artrya Secures Second US Commercial Order for Salix SaaS Platform to Manage Coronary Artery Disease
Artrya (ASX: AYA) has signed a commercial agreement with US-based Northeast Georgia Health System for the use of its Salix AI cloud platform for point-of-care assessment and management of coronary artery disease.
Biotechnology
Artrya Wins FDA Clearance to Advance Rollout of Salix Coronary Plaque Module
Artrya (ASX: AYA) has received clearance from the US Food and Drug Administration for its Salix Coronary Plaque module. The regulatory milestone enables the company to charge per-scan fees in its largest market, significantly enhancing revenue potential. The approval follows Artrya’s recent US launch and builds on momentum established with its Salix Coronary Anatomy platform. […]